Bioequivalence Study Comparing Two Budesonide/Formoterol Fumarate Dihydrate Device-metered Dry Powder Inhalers, Budesonide/Formoterol Easyhaler 200/6 microg/Inhalation and Symbicort Turbohaler 200 microg/6 microg/Inhalation.

Trial Profile

Bioequivalence Study Comparing Two Budesonide/Formoterol Fumarate Dihydrate Device-metered Dry Powder Inhalers, Budesonide/Formoterol Easyhaler 200/6 microg/Inhalation and Symbicort Turbohaler 200 microg/6 microg/Inhalation.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 17 Feb 2010

At a glance

  • Drugs Budesonide/formoterol (Primary)
  • Indications Asthma
  • Focus Pharmacokinetics
  • Acronyms KINECO
  • Sponsors Orion
  • Most Recent Events

    • 17 Feb 2010 Actual end date (Feb 2010) and actual number of patients (87) added as reported by ClinicalTrials.gov.
    • 17 Feb 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Sep 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top